Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Buyouts

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Buyouts - Share Marketability

SanFrancisco99

Jul 01, 2016 11:26AM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Buyouts - Share Marketability

in response to

Buyouts - Share Marketability

SanFrancisco99

posted on Jul 01, 2016 12:55PM

My vote is early 2017.

1 Recommendations

Re: Buyouts - Share Marketability

SanFrancisco99

Jul 01, 2016 03:11PM

Re: Buyouts - Share Marketability

KayakerBC

Jul 01, 2016 06:01PM